Palvella Therapeutics, Inc.

PVLA

Market cap$2.16 B

Rank#2076

Filings772

Palvella Therapeutics, Inc. has filed 772 public company documents between 2013 and 2026. The most frequent type is major company event (208 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchPVLA overview$2.16 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #2076See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut PVLA beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow PVLA via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
4	Insider trade	9y ago2016-11-30	2016-11-28	View filing
3	New insider ownership	9y ago2016-11-30	2016-11-28	View filing
10-Q	Quarterly report	9y ago2016-11-10	2016-09-30	View filing
8-K	Major company event	9y ago2016-11-10	2016-11-09	View filing
4	Insider trade	9y ago2016-10-27	2016-10-25	View filing
4	Insider trade	9y ago2016-10-27	2016-10-25	View filing
8-K	Major company event	9y ago2016-10-24	2016-10-21	View filing
8-K	Major company event	9y ago2016-10-05	2016-10-05	View filing
424B5	Prospectus supplement	9y ago2016-10-05	-	View filing
S-8	Employee stock plan	9y ago2016-09-23	-	View filing
8-K	Major company event	9y ago2016-09-22	2016-09-20	View filing
4	Insider trade	9y ago2016-09-22	2016-09-20	View filing
3	New insider ownership	9y ago2016-09-22	2016-09-20	View filing
CT ORDER	CT ORDER	9y ago2016-08-19	-	View filing
10-Q	Quarterly report	9y ago2016-08-11	2016-06-30	View filing
8-K	Major company event	9y ago2016-08-11	2016-08-10	View filing
424B3	424B3	9y ago2016-08-04	-	View filing
424B3	424B3	9y ago2016-08-04	-	View filing
EFFECT	EFFECT	9y ago2016-08-03	-	View filing
EFFECT	EFFECT	9y ago2016-08-03	-	View filing
EFFECT	EFFECT	9y ago2016-08-03	-	View filing
CORRESP	Company correspondence	9y ago2016-08-02	-	View filing
CORRESP	Company correspondence	9y ago2016-08-02	-	View filing
CORRESP	Company correspondence	9y ago2016-08-02	-	View filing
4	Insider trade	9y ago2016-08-01	2016-07-25	View filing
4	Insider trade	9y ago2016-08-01	2016-07-25	View filing
POS AM	POS AM	9y ago2016-07-28	-	View filing
S-3/A	S-3/A	9y ago2016-07-28	-	View filing
S-3/A	S-3/A	9y ago2016-07-28	-	View filing
8-K	Major company event	9y ago2016-07-26	2016-07-25	View filing
4	Insider trade	9y ago2016-07-26	2016-07-25	View filing
3	New insider ownership	9y ago2016-07-26	2016-07-25	View filing
CT ORDER	CT ORDER	9y ago2016-07-22	-	View filing
CT ORDER	CT ORDER	9y ago2016-07-22	-	View filing
10-Q/A	Quarterly report (amended)	9y ago2016-07-20	2016-03-31	View filing
10-K/A	Annual report (amended)	9y ago2016-07-20	2015-12-31	View filing
SC 13D/A	Activist ownership stake (update)	9y ago2016-07-12	-	View filing
S-3	Securities registration	10y ago2016-07-08	-	View filing
8-K	Major company event	10y ago2016-07-01	2016-06-28	View filing
POS AM	POS AM	10y ago2016-06-24	-	View filing
SC 13G	Passive ownership stake	10y ago2016-06-17	-	View filing
D	D	10y ago2016-06-15	-	View filing
4	Insider trade	10y ago2016-06-15	2016-06-13	View filing
4	Insider trade	10y ago2016-06-15	2016-06-13	View filing
4	Insider trade	10y ago2016-06-15	2016-06-13	View filing
424B3	424B3	10y ago2016-06-09	-	View filing
8-K	Major company event	10y ago2016-06-09	2016-06-08	View filing
424B3	424B3	10y ago2016-06-09	-	View filing
8-K	Major company event	10y ago2016-06-08	2016-06-08	View filing
8-K	Major company event	10y ago2016-06-06	2016-06-06	View filing

Palvella Therapeutics, Inc.

Similar companies to research next

Year